The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Glucagonlike peptide 1: A newly discovered gastrointestinal hormone
Abstract
Glucagonlike peptide (GLP) 1, a peptide of 30 amino acids with 50% sequence homology to glucagon, results from expression of the glucagon gene in the L cells of the distal intestinal mucosa. It is secreted early in response to mixed meals by mechanisms involving the presence of unabsorbed nutrients in the gut lumen or the absorptive process itself, but other mechanisms may also be involved. GLP-1 has two important actions. First, it stimulates insulin secretion and inhibits glucagon secretion and thereby inhibits hepatic glucose production and lowers blood glucose levels. It may have effects on glucose clearance independent of its pancreatic effects. It acts on recently cloned G protein-coupled specific receptors and seems to increase insulin secretion via cyclic adenosine monophosphate-dependent increases in intracellular calcium. It has been suggested that activation of the beta cells by GLP-1 is a prerequisite for glucose-induced insulin secretion. Second, it also potently inhibits gastrointestinal secretion and motility and is likely to act as an "ileal brake," possibly after activation of cerebral receptors. Therefore, GLP-1 physiologically seems to signal nutritional abundancy and enhance deposition of nutrients. Because of these effects, however, the peptide can completely normalize blood glucose levels in type 2 diabetics and is therefore of considerable pharmaceutical interest.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, the deepened appreciation for the role that glucagon has on energy expenditure has placed this hormone in a new light, and rekindled its consideration as a component that could provide additional weight loss when needed, or to sustain the weight loss that may otherwise wane through some form of supplementation70.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [70]
Citations
Cites
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Self-citationMENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161
Nauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092
Self-citationTissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 919
Self-citationThorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Self-citationGöke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36565-2 · Cited by 837
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Research works printed but not linked: 9
- Herrmann, 1993, Regulation of glucagon-like peptide (GLP-1) release from the isolated perfused rat ileum by nutrients, peptides and neuromediators, Digestion, 54, 367
- Holst, 1986, Proglucagon 78–107, a potent insulinotropic hormone from lower small intestine (abstr), Diabetologia, 29, 549A
- Qualmann, 1992, Negligible insulinotropic action of exogenous glucagon-like peptide-1 [7–36 amide] at basal plasma glucose concentration in healthy volunteers (abstr), Diabetologia, 35, A109
- Gromada, 1993, Induction of glucose responsiveness in pancreatic β-cells by glucagon-like peptide-1 (abstr), Diabetologia, 36, A39
- Delgado, 1993, Identification and characterization of GLP-1(7–36)amide receptors in rat skeletal muscle (abstr), Diabetologia, 36, A39
- Layer, 1991, Inhibition of pancreatic enzyme output in response to ileal perfusion with nutrients is associated with release of glucagon-like peptide-1 (GLP-1) in humans (abstr), Pancreas, 6, 708
- Layer, 1993, GLP-1: a humoral mediator of the ileal brake in humans?, Digestion, 54, 385
- Holst JJ, Vaag A, Beck-Nielsen H. Decreased GLP-1 secretion in NIDDM—studies in identical twins discordant for NIDDM. American Diabetes Society (in press).
- Gutniak, 1993, GLIP (glucagon-like insulinotropic peptide) has a stronger antidiabetogenic effect than glibenclamide (abstr), Diabetologia, 36, A38
Cited by
Pories, W. J., Swanson, M. S., MacDonald, K. G., Long, S. B., Morris, P. G., Brown, B. M., Barakat, H. A., deRamon, R. A., Israel, G., Dolezal, J. M., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00011 · Cited by 2,293
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Villhauer, E. B., Brinkman, J. A., Naderi, G. B., Burkey, B. F., Dunning, B. E., Prasad, K., Mangold, B. L., Russell, M. E., & Hughes, T. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030091l · Cited by 613
Drucker, D. J. (1998) · Diabetes · doi:10.2337/diab.47.2.159 · Cited by 601
Reubi, J. C., & Waser, B. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1184-3 · Cited by 592
Metadata
- Authors
- Holst, J. J.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Holst, Jens Juul
- ORCID
- Holst, Jens Juul
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1994-12
- Volume
- 107
- Issue
- 6
- Pages
- 1848-1855
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1482009781
- Cited by
- 252
- References
- 86
- Citations by year
- 2025: 2 · 2024: 7 · 2023: 6 · 2022: 2 · 2021: 9 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 5 · 2015: 6 · 2014: 4 · 2013: 12 · 2012: 12
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucagon-like peptide-1, gastrointestinal hormones, L cells, intestinal mucosa, insulin secretion, glucagon secretion, hepatic glucose production, glucose clearance, G protein-coupled receptors, cyclic AMP, intracellular calcium, gastrointestinal motility, ileal brake, type 2 diabetes, blood glucose regulation
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Gastrointestinal Hormones, Glucagon, Humans, Insulin, Liver, Peptides, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucagonlike peptide 1: A newly discovered gastrointestinal hormone. https://app.cochat.ai/papers/10.1016/0016-5085(94)90831-1
- The paper
- Holst, J. J. (1994). Glucagonlike peptide 1: A newly discovered gastrointestinal hormone. Gastroenterology. https://doi.org/10.1016/0016-5085(94)90831-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.